Latest news from the Science Center, the companies we support and the innovation ecosystem.
December 16, 2016 | Resident & Alumni News
This Handheld Breast Scan Is Revolutionizing How Indians Detect Cancer
For 18-year-old Farheen Jahan, life took an ugly turn when she discovered a stiff growth in her breast. However, initial blood reports failed to detect anything serious. Later, in a health camp clinic set up in her locality in rural India she got herself scanned again with something called iBreastExam – a diagnostic tool designed to perform painless and radiation free breast scans, providing results instantly at the point of care.
Veriflow Product Line To Detect Foodborne Pathogens Continues Expansion With Additional Aoac Approval
Invisible Sentinel, Inc., a Philadelphia-based global molecular solutions company announced today that its Veriflow technology platform for the detection of STEC organisms received certification from the Association of Analytical Communities (AOAC).
USDA and AUM LifeTech develop a novel Non-GMO RNA silencing approach against citrus greening with a goal to save the troubled $40 billion global citrus industry
AUM LifeTech in collaboration with the United States Department of Agriculture has developed a novel Non-GMO RNA silencing approach for bacteria, insect and pathogen control with a focus on citrus trees and fruits. Huanglongbing, a fatal bacterial citrus disease, also known as citrus greening has already caused an estimated $15 billion loss in revenue to the industry.
BBC’s ‘100 Women 2016’ list features ROAR for Good’s Yasmine Mustafa
As ROAR for Good keeps working on its flagship Athena product (slated to ship early 2017, last time we checked), CEO Yasmine Mustafa landed some more press. This time, it’s international, thanks to a spot on BBC’s 100 Women 2016 list, published on Monday.
Drug development is a risky—and costly—business. Many promising compounds fail to cut the mustard when put through clinical trials. One reason is that drugs which work on laboratory animals may not work quite so well in human tests.
Startup wants to go beyond pencils to improve patient monitoring for psychiatric patients
Behavioral health has been a growing area of interest for digital health. But most companies have avoided clinical settings, particularly psychiatric hospitals. Philadelphia company InvisALERT Solutions is developing a workflow tool using a wearable-based patient monitoring platform to improve safety for psychiatric inpatients.
Choosito! And Quick Key Partner To Deliver Curated, Personalized Learning Content Based On Quizzes And Quiz Results
Choosito! Inc., curator of open Web content for learning and National Science Foundation Business Innovation Award winner, and Quick Key, maker of mobile assessment software, have partnered to offer students personalized learning content based on quizzes and other data.
GraphWear Technologies pilots sweat sensor patch with NFL team
GraphWear Technologies is piloting its sweat assessment wearable patch with a professional football team. The pilot involves tracking glucose and electrolyte levels by analyzing users’ sweat. The greater goal is to keep users hydrated and provide a way of alerting athletes when they need to replenish their liquids.
Philadelphia Medical Software Startup Aims To Bridge ‘Neurologist Gap’
Smaller hospitals don’t always have a neurologist on duty around the clock to read patients’ EEGs, which measure electrical activity in the brain. But a startup based at the University City Science Center in Philadelphia wants to change that.
AUM LifeTech's next generation FANA RNA silencing technology showcased in several studies at Oligonucleotide Therapeutics Society Meeting in Montreal, Canada
UM LifeTech, Inc. has successfully developed multiple applications for its next generation FANA RNA silencing technology to advance biomedical research and therapeutic development. Conventional RNA silencing technologies like siRNAs and shRNAs have a lot of issues some of which include off target effects, toxicity, less potency, poor stability and most importantly they need transfection agents or expression vector systems for delivery into cells or animal models.